Kirin Holdings Co Ltd
Consumer Staples
Current price
Target price 00%
Ranks rating
76
Position in sub-industry
57 / 89
Position in country
3608 / 4811
Return on Assets, %
5.5
4.3
Net income margin, %
7.1
4.8
EBITDA margin, %
13.4
12.4
Debt to Equity, %
57.9
27.8
Intangible assets and goodwill, %
24.1
1.3
Revenue CAGR 3Y, %
4.8
8
Total Equity change 1Y, %
7.4
0.7
Revenue Y, % chg
0.7
3.5
P/E
15.4
19.9
P/BV
1.5
2
P/S
0.9
1.1
EV/S
1.3
1.5
EV/EBITDA
10.3
8.5
Average Analyst recommendation
Hold
Hold
Average upside forecasts, %
13.1
18.9
Forward P/E
13.6
17
Dividend Yield, %
3.3
3.6
Forward Dividend Yield, %
3
0.5
Expected dividend per share
0.4
0.2
Payout Ratio, %
51.1
51.5
Competitors
Ranks
-
Heineken Holding NV
00%
-
Carlsberg A/S
00%
-
Chongqing Brewery Co Ltd
00%
-
Heineken NV
00%
-
Ambev SA
00%
-
Asahi Group Holdings Ltd
00%
-
Budweiser Brewing Company APAC Ltd
00%
-
Kirin Holdings Co Ltd
00%
-
Sapporo Holdings Ltd
00%
-
Anheuser-Busch Inbev SA
00%
Ready-made portfolio of the best Russian stocks
- Created by artificial intelligence
- Verified by analysts
- Available even to beginners
Company information
Country
Japan
Sector
Consumer Staples
Industry group
Food, Beverage & Tobacco
Industry
Beverages
Sub-sector
Consumer Staples
Capitalization (millions of $)
13056.7
Ticker
KNBWY.PK
ISIN
US4973503067
IPO date
1949-05-16
Availability on Russian exchanges
No
Reporting for
2024-03-28
Date fact. publication of reports
2023-12-31
Company Description
Kirin Holdings Company, Limited is a Japan-based company mainly engaged in the integrated beverage business and the pharmaceutical business. The Company operates in four business segments. The Domestic Beer and Spirits segment is engaged in the manufacture and sale of beer, low-malt beer, new genre products, wines and other liquor products in Japan. The Domestic Beverages segment is engaged in the manufacture and sale of soft drinks in Japan. The Oceania Integrated Beverages segment is engaged in the manufacture and sale of beer, wines, dairy products, juice drinks and other products in the Oceania region. The Pharmaceuticals segment is engaged in the manufacture and sale of pharmaceutical products. The Company is also engaged in the domestic wine business, the liquor business in Myanmar, the beverage business in North American, and the biochemical business.
A step towards better analytics
- find the best promotions through the Screener
- keep an eye on stock valuation
- download detailed reports
and much more after free registration
RegistrationMore convenient from your phone? Download: